Vector Science & Therapeutics develops novel biomechanical devices and active transdermal drug delivery platforms to equip clinicians with non-systemic, localized intervention for non-narcotic pain management and regeneration of musculoskeletal tissue.
We are committed to improving the lives of patients and the practice of medicine by developing and commercializing technologies that
Improve clinical outcomes,
Reduce the economic burden of treatment for patients and payers,
Leverage insight secured across the patient’s journey with our products to equip medical professionals to deliver personalized intervention.
Vector Science & Therapeutics is traded on the TSX Venture Exchange (TSXV). The TSXV of the Toronto Stock Exchange (TSX) focuses on early-stage and emerging companies.
If you are an investor or clinician seeking to learn more about Vector, please email us at info@vectorscience.co and a member of our team will reach out
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.